Shares of Inovio Pharmaceuticals Inc. INO slipped 3.61% to $5.34 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.06 ...

In the past month, shares of INO have skyrocketed 134.2% compared with the industry’s 6.5% rise. The significant uptick in the stock price was observed after the company announced plans to ...

The sudden soaring of the stock price was observed after Inovio announced that its lead DNA medicine candidate, INO-3107, has received the Innovation Passport designation under the United Kingdom ...

Shares of Inovio Pharmaceuticals Inc. INO inched 0.36% higher to $5.54 Friday, on what proved to be an all-around favorable ...

Short interest in Inovio Pharmaceuticals Inc (NASDAQ:INO) increased during the last reporting ... on the decline of Inovio Pharmaceuticals's stock. Short interest data is updated every two weeks.

Innovio announced the presentation of new data at scientific conferences for its lead candidate, INO-3107, for which the company is preparing a Biologics License Application for targeted ...

Autolus Therapeutics (AUTL) announces the online publication of four abstracts submitted to the American Society of Hematology, ASH, Annual ...

TORONTO, October 08, 2024--Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) announced today that, further to its press releases dated July 15, 2024, August 27, 2024, and September 4, ...